Comparison of Preeclampsia Rates in Pregnant Women with Mild vs. Moderate-to-Severe Systemic Lupus Erythematosus
DOI:
https://doi.org/10.26911/thejmch.2024.09.05.07Abstract
Background: Preeclampsia is one of the leading causes of maternal mortality in Indonesia and is often associated with autoimmune conditions, such as Systemic Lupus Erythematosus (SLE). Therefore, this study aimed to compare the proportion of preeclampsia in pregnant women with mild and moderate-severe SLE.
Subjects and Method: This cross-sectional design conducted in RSUD Dr. Moewardi. The population consisted of pregnant women with SLE treated at RSUD Dr. Moewardi between 2021 and 2023. A total of 77 pregnant patients with SLE selected from this study. The dependent variable was preeclampsia. The independent variable was pregnant women with SLE. This study utilized tools and materials in the form of medical record data from the Obstetrics and Gynecology Department at Dr. Moewardi Hospital, Surakarta. Data were analyzed using bivariate analysis with SPSS software and Fisher’s exact test tests.
Results: A total of 77 subjects who met the inclusion criteria. Subjects with moderate-severe degrees had preeclampsia 28.6% (n = 4). While subjects with mild degrees experienced preeclampsia 20.6% (n = 13). There was no significant relatoionship between the degree of systemic lupus erythematosus activity and preeclampsia (p = 0.496).
Conclusion: This study showed no significant association between the degree of systemic lupus erythematosus activity and preeclampsia.
Keywords:
systemic lupus erythematosus, pre-eclampsia, pregnancyReferences
Accapezzato D, Caccavale R, Paroli MP, Gioia C, Nguyen BL, Spadea L, Paroli M (2023). Advances in the pathogenesis and treatment of systemic lupus erythematosus. Int J Mol Sci. 24(7):6578. doi: 10.3390/ijms2407-6578.
Akbar MIA (2019). SLE dalam Kehamilan (SLE in Pregnancy). Surabaya: Airlangga University Press.
Andrade D, Kim M, Blanco LP, Karumanchi SA, Koo GC, Redecha P, Kirou K, et al. (2015). Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheumatolo. 67(4): 977–987. https://doi.org/10.1002/art.39029.
Basyiar A, Mamlukah M, Iswarawanti DN, Wahyuniar L (2021). Faktor risiko yang berhubungan dengan kejadian preeklampsia pada ibu hamil trimester ii dan iii di Puskesmas Cibeureum Kabupaten Kuningan tahun 2019 (Risk factors associated with the incidence of preeclampsia in pregnant women in the second and third trimesters at the Cibeureum Health Center, Kuningan Regency in 2019). Journal of Public Health Innovation. 2(1): 50–60. https://doi.org/10.34305/jphi.v2i1.331.
Bokslag A, van Weissenbruch M, Mol BW, de Groot CJM (2016). Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev. 102: 47–50. https://doi.org/10.1016/j.earlhumdev.2016.09.007
De Groot PG, Urbanus RT (2012). The significance of autoantibodies against β2-glycoprotein I. Blood. 120(2): 266–274. https://doi.org/10.1182/blood201203378646
Fatmawati A (2018). Regulasi diri pada penyakit kronis - systemic lupus erythematosus: kajian literatur (Self-regulation in chronic disease – systemic lupus erythematosus: a literature review). Jurnal Keperawatan Indonesia. 21(1). 43–50. https://doi.org/10.7454/jki.v21i1.542.
Fox R, Kitt J, Leeson P, Aye CYL, Lewan-dowski A J (2019). Preeclampsia: risk factors diagnosis. management and the cardiovascular impact on the offspring. J Clin Med. 8(10): 1625. https://doi.org/10.3390/jcm8101625.
Gluhovschi C, Gluhovschi G, Petrica L, Velciov S, Gluhovschi A (2015a). pregnancy associated with systemic lupus erythematosus: immune tolerance in pregnancy and its deficiency in systemic lupus erythematosus - an immunological dilemma. J Immunol Res. 2015:241547. https://doi.org/10.1155/2015/241547.
Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, Gotsch F, Erez O (2022). The etiology of preeclampsia. Am J Obstetr Gynecol. 226(2): S844–S866. https://doi.org/10.1016/j.ajog.2021.11.1356.
Khan B, Yar R A, Khakwani A khan Karim S, Ali HA (2022). Preeclampsia incidence and its maternal and neonatal outcomes with associated risk factors. Cureus. 14(11). https://doi.org/10.7759/CUREUS.31143
Kumalasari I, Maksuk, Yuniati F, Rangga AD, Fathurrahman MD, Aulia E (2023). Pengembangan aplikasi “DELIMA” sebagai upaya deteksi dini kehamilan bermasalah (Development of “DELIMA” app as an effort for early detection of risky pregnancy). Jurnal Kesehatan. 12(1): 124–132. https://doi.org/10.46815/jk.v12i1.134.
Muzalfah R, Dyah Puspita Santik Y, Setyo Wahyuningsih A (2018). Kejadian preeklampsia pada ibu bersalin. Higeia J Public Health Res Develop. https://doi.org/10.15294/higeia/v2i3/21390
Ramos JGL, Sass N, Costa SHM (2017). Preeclampsia. Rev Bras Ginecol Obstet. 39(9): 496–512. https://doi.org/10.1055/s00371604471.
Rosta K, Heinzl F, Kuczwara V, Schindler S, Falcone V, Catic A, Riedmann M, et al. (2024). Pregnancy outcomes in patients with systemic lupus erythematosus compared to a high-risk tertiary cohort and to standard population from the Austrian birth registry. Acta Obstetricia et Gynecologica Scandinavica. 103(9). 1820–1828. https://doi.org/10.1111/aogs.14880.
Simard JF, Arkema EV, Nguyen C, Svenungsson E, Wikström AK, Palmsten K, Salmon JE (2017). Early-onset preeclampsia in lupus pregnancy. Paediatr Perinat Epidemiol. 31(1): 29–36. https://doi.org/10.1111/ppe.12332
Sumariyono, Kalim H, Setyohadi B, Hidayat R, Najirman, Hamijoyo L, Wijaya LK, et al. (2019). Diagnosis dan pengelola lupus eritematosus sistemik (Diagnosis and management of systemic lupus erythematosus). Perhimpunan Reumatologi Indonesia.
Tanzilia MF, Tambunan BA, Dewi DNSS (2021). Tinjauan pustaka: patogenesis dan diagnosis sistemik lupus eritematosus (Literature review: pathogenesis and diagnosis of systemic lupus erythematosus). Syifa’ Medika. 11(2): 149-164. https://doi.org/10.32502/sm.v11i2.2788.
Yang Y, Le RI, Zhu J, Zhang J, Hua J, Reilly M (2021). preeclampsia prevalence. risk factors. and pregnancy outcomes in Sweden and China. JAMA Network Open. 4(5). E218401.https://doi.org/10.1001/jamanetworkopen.2021.8401
Yue E, Kwan, Rita C, Hamijoyo, Laniyati (2017). Outcome of pregnancy in patients with systemic lupus erythematosus. Indonesia J Rheumatol. 9(2): 27-30. http://dx.doi.org/10.37275/ijr.v9i2.74.
Zamani B, Shayestehpour M, Esfahanian F, Akbari H (2020). The study of factors associated with pregnancy outcomes in patients with systemic lupus erythematosus. BMC Research Notes. 13(1). https://doi.org/10.1186/s13104020050399.
Zhu T, Zhan G, Shang Z, Ying Z (2024). Causal relationship between systemic lupus erythematosus and adverse pregnancy outcomes A two-sample Mendelian randomized study. Heliyon 10(15): e35401. https://doi.org/10.1016/J.HELIYON.2024.E35401
